Safety of erythropoiesis-stimulating agents in patients with end-stage kidney disease: Data are safer than extrapolations

Ivo Abraham, Karen MacDonald

Research output: Contribution to journalReview articlepeer-review

4 Scopus citations

Fingerprint Dive into the research topics of 'Safety of erythropoiesis-stimulating agents in patients with end-stage kidney disease: Data are safer than extrapolations'. Together they form a unique fingerprint.